Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1636
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18296350 | METHODS FOR REGULATING BLOOD-CENTRAL NERVOUS SYSTEM (BLOOD-CNS) BARRIER AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 17800417 | COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR TREATING RNA VIRUS INFECTIONS | Non-Final OA | The Regents of the University of California |
| 17849132 | METHODS AND COMPOSITIONS FOR INHIBITING CORONAVIRAL REPLICATION | Non-Final OA | California Institute of Technology |
| 18814161 | Deaminase-Based RNA Sensors | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18032868 | REPROGRAMMABLE ISCB NUCLEASES AND USES THEREOF | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18276163 | METHODS FOR MANUFACTURING A SYNTHETIC TEMPLATE | Non-Final OA | Nutcracker Therapeutics, Inc. |
| 18262792 | PREVENTIVE OR THERAPEUTIC AGENT FOR BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY | Non-Final OA | RIKEN |
| 18330563 | SUMO Targeting Morpholinos as both Enhancers of Anti-Cancer Effects of Chemotherapeutic Treatments and Preventative Agents Against the Establishment of Chemoresistance | Non-Final OA | Board of Regents, The University of Texas System |
| 16838960 | GENOMIC SEQUENCE MODIFICATION METHOD FOR SPECIFICALLY CONVERTING NUCLEIC ACID BASES OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX FOR USE IN SAME | Non-Final OA | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY |
| 17928028 | MODULAR PLATFORM FOR PROGRAMMABLE SPATIOTEMPORAL BIOMOLECULE CLUSTERING WITH APPLICATIONS INCLUDING ENHANCED METABOLIC YIELD | Non-Final OA | The Trustees of Princeton University |
| 17613387 | COMPOSITIONS AND METHODS FOR CD33 MODIFICATION | Non-Final OA | VOR BIOPHARMA INC. |
| 18546024 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY | Non-Final OA | Institut Pasteur |
| 18253977 | USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION | Non-Final OA | CELLECTIS SA |
| 17836304 | Nucleic Acid Carriers And Therapeutic Methods Of Use | Non-Final OA | Code Biotherapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy